These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
558 related articles for article (PubMed ID: 38727281)
1. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies. Pazzin DB; Previato TTR; Budelon Gonçalves JI; Zanirati G; Xavier FAC; da Costa JC; Marinowic DR Cells; 2024 Apr; 13(9):. PubMed ID: 38727281 [TBL] [Abstract][Full Text] [Related]
2. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing. Yin X; Li Q; Shu Y; Wang H; Thomas B; Maxwell JT; Zhang Y J Biomed Sci; 2024 May; 31(1):47. PubMed ID: 38724973 [TBL] [Abstract][Full Text] [Related]
3. From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases. Bordoni M; Rey F; Fantini V; Pansarasa O; Di Giulio AM; Carelli S; Cereda C Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544711 [TBL] [Abstract][Full Text] [Related]
4. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders. Lee CT; Bendriem RM; Wu WW; Shen RF J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354 [TBL] [Abstract][Full Text] [Related]
5. The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases. Peng J; Zeng X Stem Cell Res Ther; 2011 Jul; 2(4):32. PubMed ID: 21861938 [TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality? Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029 [TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine. Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424 [TBL] [Abstract][Full Text] [Related]
8. Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine. Summers RA; Fagiani F; Rowitch DH; Absinta M; Reich DS Trends Immunol; 2024 Oct; 45(10):799-813. PubMed ID: 39307583 [TBL] [Abstract][Full Text] [Related]
9. Experimental Cell Models for Investigating Neurodegenerative Diseases. Evangelisti C; Ramadan S; Orlacchio A; Panza E Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273694 [TBL] [Abstract][Full Text] [Related]
10. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease. Wu YY; Chiu FL; Yeh CS; Kuo HC Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120 [TBL] [Abstract][Full Text] [Related]
11. Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia. Albert K; Niskanen J; Kälvälä S; Lehtonen Š Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919317 [TBL] [Abstract][Full Text] [Related]
12. Central nervous system organoids for modeling neurodegenerative diseases. Hou PS; Kuo HC IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668 [TBL] [Abstract][Full Text] [Related]
13. Cerebral Organoids-Challenges to Establish a Brain Prototype. Eremeev AV; Lebedeva OS; Bogomiakova ME; Lagarkova MA; Bogomazova AN Cells; 2021 Jul; 10(7):. PubMed ID: 34359959 [TBL] [Abstract][Full Text] [Related]
14. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]
15. iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review. Ali EAM; Smaida R; Meyer M; Ou W; Li Z; Han Z; Benkirane-Jessel N; Gottenberg JE; Hua G Stem Cell Res Ther; 2024 Jun; 15(1):185. PubMed ID: 38926793 [TBL] [Abstract][Full Text] [Related]
16. Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease modeling, and toxicology testing. Salas-Silva S; Kim Y; Kim TH; Kim M; Seo D; Choi J; Factor VM; Seo HR; Song Y; Choi GS; Jung YK; Kim K; Lee KG; Jeong J; Shin JH; Choi D Biomaterials; 2023 Dec; 303():122360. PubMed ID: 38465578 [TBL] [Abstract][Full Text] [Related]
17. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases]. Ito D; Yagi T; Suzuki N Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520 [TBL] [Abstract][Full Text] [Related]
18. Investigating pediatric disorders with induced pluripotent stem cells. Durbin MD; Cadar AG; Chun YW; Hong CC Pediatr Res; 2018 Oct; 84(4):499-508. PubMed ID: 30065271 [TBL] [Abstract][Full Text] [Related]
19. Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases. Cao L; Tan L; Jiang T; Zhu XC; Yu JT Mol Neurobiol; 2015 Aug; 52(1):244-55. PubMed ID: 25146848 [TBL] [Abstract][Full Text] [Related]
20. Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy. Zhang T; Qian C; Song M; Tang Y; Zhou Y; Dong G; Shen Q; Chen W; Wang A; Shen S; Zhao Y; Lu Y Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]